Schonfeld Strategic Advisors LLC Celldex Therapeutics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 119,629 shares of CLDX stock, worth $3.44 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
119,629Holding current value
$3.44 Million% of portfolio
0.03%Shares
9 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
63.5MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$232 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$135 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$108 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$97.5 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$95.7 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.35B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...